lilly tirzepatide - Search News

Cipla, India and Eli Lilly

· 2d · on MSN

Eli Lilly allows Cipla to sell weight loss drug under new brand in India

Eli Lilly signed an agreement with Cipla, allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate brand in the country, the companies said on Thursday. Under the agreement,

Continue reading

The Pharma Letter · 13h

Cipla and Eli Lilly partner to launch tirzepatide as Yurpeak in India

· 2d · on MSN

Eli Lilly gives Cipla license to sell weight-loss drug Tirzepatide in India

3don MSN

3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

4dOpinion

Eli Lilly Vs Novo Nordisk: One To Walk Away From And One To Run Away From

Discover how potential U.S. price cuts on obesity drugs could impact LLY and NVO revenues, stock sentiment, and valuation ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results